{
    "ticker": "OTGLY",
    "name": "Otsuka Pharmaceutical Co., Ltd.",
    "description": "Otsuka Pharmaceutical Co., Ltd. is a global healthcare company headquartered in Tokyo, Japan, dedicated to the research and development of innovative pharmaceuticals and nutraceuticals. Founded in 1964, Otsuka aims to contribute to the health and well-being of people worldwide. The company is particularly known for its focus on mental health and central nervous system disorders, with flagship products such as Abilify (aripiprazole), a widely prescribed antipsychotic medication. Otsuka also invests in a diverse range of therapeutic areas, including oncology, cardiovascular, and infectious diseases. Beyond pharmaceuticals, Otsuka is committed to creating new value through its nutraceuticals division, which focuses on dietary supplements and functional foods that promote health and wellness. The company emphasizes a holistic approach to health, integrating both medical and lifestyle solutions. With a strong commitment to sustainability, Otsuka engages in numerous initiatives aimed at reducing its environmental impact and improving access to healthcare. The company operates globally, with a presence in over 20 countries and regions, ensuring that its innovative products reach those in need. Otsuka's mission is to create a healthier world through the power of science, and it continues to explore novel treatments and solutions that address unmet medical needs.",
    "industry": [
        "Pharmaceuticals",
        "Healthcare"
    ],
    "headquarters": "Tokyo, Japan",
    "founded": "1964",
    "website": "https://www.otsuka.com",
    "ceo": "Katsuhiko Otsuka",
    "social_media": {
        "twitter": "https://twitter.com/otsukacompany",
        "linkedin": "https://www.linkedin.com/company/otsuka-pharmaceutical-co-ltd/"
    },
    "investor_relations": "https://www.otsuka.com/en/ir/",
    "key_executives": [
        {
            "name": "Katsuhiko Otsuka",
            "position": "CEO"
        },
        {
            "name": "Akira Otsuka",
            "position": "CFO"
        }
    ],
    "product_categories": [
        {
            "category": "Pharmaceuticals",
            "products": [
                "Abilify",
                "Seroquel",
                "Lonsurf"
            ]
        },
        {
            "category": "Nutraceuticals",
            "products": [
                "Pocari Sweat",
                "Soyjoy"
            ]
        }
    ],
    "seo": {
        "meta_title": "Otsuka Pharmaceutical Co., Ltd. | Innovating Health Solutions",
        "meta_description": "Explore Otsuka Pharmaceutical Co., Ltd., a global leader in healthcare committed to innovative pharmaceuticals and nutraceuticals. Learn about our mission to improve health and well-being worldwide.",
        "keywords": [
            "Otsuka",
            "Pharmaceuticals",
            "Healthcare",
            "Abilify",
            "Nutraceuticals",
            "Mental Health"
        ]
    },
    "faq": [
        {
            "question": "What is Otsuka known for?",
            "answer": "Otsuka is known for its innovative pharmaceuticals, particularly in mental health, as well as its nutraceutical products."
        },
        {
            "question": "Who is the CEO of Otsuka?",
            "answer": "Katsuhiko Otsuka is the CEO of Otsuka Pharmaceutical Co., Ltd."
        },
        {
            "question": "Where is Otsuka headquartered?",
            "answer": "Otsuka is headquartered in Tokyo, Japan."
        },
        {
            "question": "What are Otsuka's main products?",
            "answer": "Otsuka's main products include Abilify, Lonsurf, Pocari Sweat, and Soyjoy."
        },
        {
            "question": "When was Otsuka founded?",
            "answer": "Otsuka was founded in 1964."
        }
    ],
    "competitors": [
        "MRK",
        "PFE",
        "JNJ",
        "BMY"
    ],
    "related_stocks": [
        "AAPL",
        "GOOGL",
        "AMZN",
        "MSFT"
    ]
}